BRIEF-AstraZeneca Provides Update on Evusheld US EUA

AstraZeneca PLC: * UPDATE ON EVUSHELD US EUA

* TO CONTINUE TO WORK WITH FDA, OTHER HEALTH AUTHORITIES TO COLLECT, ASSESS, SHARE RELEVANT DATA REGARDING EVUSHELD AND SARS-COV-2 VARIANTS * EVUSHELD REMAINS AUTHORISED IN OTHER COUNTRIES WHERE IT IS APPROVED FOR COVID PRE-EXPOSURE PROPHYLAXIS,TREATMENT, INCLUDING EU AND JAPAN Source text for Eikon: Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)